NCT00945984

Brief Summary

Surgical resection is the only potential curative treatment available for renal cell carcinoma. The purpose of this study is to clarify the surgical and oncologic outcomes of laparoendoscopic single-site radical nephrectomy for localized Renal Cell Carcinoma.

Trial Health

55
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
36

participants targeted

Target at P25-P50 for all trials

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

March 1, 2009

Completed
5 months until next milestone

First Submitted

Initial submission to the registry

July 22, 2009

Completed
2 days until next milestone

First Posted

Study publicly available on registry

July 24, 2009

Completed
Last Updated

July 28, 2009

Status Verified

July 1, 2009

First QC Date

July 22, 2009

Last Update Submit

July 25, 2009

Conditions

Localized Renal Cell Carcinoma

Keywords

Localized renal cell carcinoma

Outcome Measures

Primary Outcomes (1)

  • Surgical outcomes such as operative time, estimated blood loss

    1 year

Study Arms (2)

LESS

Patients who underwent LESS radical nephrectomy

Procedure: Radical nephrectomy

Conventional laparoscopy

Patients who underwent conventional laparoscopic radical nephrectomy

Procedure: Radical nephrectomy

Interventions

Radical nephrectomyPROCEDURE

Surgical options to treat localized renal cell carcinoma

Conventional laparoscopyLESS

Eligibility Criteria

Age20 Years - 80 Years
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodProbability Sample
Study Population

Tertiary care center

You may qualify if:

  • Patients with localized renal cell carcinoma

You may not qualify if:

  • Patients with lymph node or distant metastasis

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Seoul National University Hospital

Seoul, 110-744, South Korea

Location

Study Officials

  • Hyeon Hoe Kim, PhD

    Seoul National University Hospital

    STUDY CHAIR

Study Design

Study Type
observational
Observational Model
CASE CONTROL
Time Perspective
RETROSPECTIVE
Sponsor Type
OTHER

Study Record Dates

First Submitted

July 22, 2009

First Posted

July 24, 2009

Study Start

March 1, 2009

Last Updated

July 28, 2009

Record last verified: 2009-07

Locations

KR(1)